References
- Biesterfeld , C. H. 1949 . Patent Law for Lawyers, Students, Chemists and Engineers , (2nd Edition) , New York : John Wiley .
- Food and Drug Administration . 1987 . Guideline for the Format and Content of the Nonclinical Pharmacology/Toxicology Section of an Application , Rockville : Food and Drug Administration .
- Juran , J. M. 1974 . “ Basic Concepts ” . In Quality Control Handbook , (3rd Edition) , Edited by: Juran , J. M. , Gryna , F. M. Jr. and Bingham , R. S. Jr. New York : McGraw‐Hill .
- Kitch , E. W. 1973 . “ The Patent System and the New Drug Application: an Evaluation of the Incentives for Private Investment in New Drug Research and Marketing ” . In Regulating New Drugs , Edited by: Landau , R. L. Chicago : University of Chicago Center for Public Policy .
- Maynard , J. T. 1978 . Understanding Chemical Patents a Guide for the Inventor , Washington, D.C. : American Chemical Society .
- Office of the Federal Register . 1988 . Code of Federal Regulations, Title 21 , Washington, D.C. : General Services Administration .
- 1983 . PMA Guidelines for the Preparation and Control of Clinical Supplies , Washington, D.C. : Pharmaceutical Manufacturer's Association .
- 1982 . PMA Position Paper , The Role of the LD50 Determination in Drug Safety Evaluation Washington, D.C. : Pharmaceutical Manufacturers Association .
- Young , F. 1987 . Strengthening the FDA Through Stability, Modernization, and Statemanship , Washington, D.C. : Speech to Food and Drug Law Institute .
- I wish to thank Dr. John Donahue, Vice‐President, Worldwide Regulatory Compliance, SmithKline Beckman Corporation, for his many helpful comments, suggestions, and editorial services.